Caroline J Witton Warner
机构: Research Scientist, Agilent
每年引用次数
引用次数
引用: 2,366
H-指数: 13
I10-指数 : 14
出版物: 37
Increased systemic stability, tumor accumulation and in vitro and in vivo efficacy of a secretory phospholipase 2-degradable liposomal form of cisplatin.
Birgitte Toft , Margit Baeksted , Kent Jorgensen , Frederik Dagnaes-Hansen
Cancer Research 68 5618 -5618
2008
Abstract# 638: Secretory phospholipase A2-degradable liposomal formulations of cisplatin and oxaliplatin: Pre-clinical results
Fredrik Melander , Mats Leeman , Anders Vikbjerg , Morten Petersen
Cancer Research 69 ( 9_Supplement) 638 -638
2009
Improved properties of a secretory phospholipase 2-degradable liposomal form of oxaliplatin.
Fredrik Melander , Caroline Witton , Jakob Larsen , Mats Leeman
Cancer Research 68 ( 9_Supplement) 5617 -5617
2008
Allelic imbalance of dihydrofolate reductase, thymidine phosphorylase, and thymidylate synthase in colorectal cancer; Significance to prognosis
Soren A Jensen , Ben Vainer , Caroline Witton , Kirsten V Nielsen
ANNALS OF ONCOLOGY 17 247 -247
2006
Array CGH identifies genes commonly amplified in breast carcinoma
C. J. Witton , J. M. S. Bartlett , T. Ruffalo , T. G. Cooke
Breast Cancer Research and Treatment 82(Suppl 1 116
2003
Do molecular markers predict when to implement aromatase inhibitor therapy in invasive breast cancer
S. Tovey , B. Dunne , C. J. Witton , A. Forsyth
Journal of Clinical Oncology 23 ( 16_suppl) 9559 -9559
2005
Injection of a boar sperm factor causes calcium oscillations in oocytes of the marsupial opossum, Monodelphis domestica.
C. J. Witton , K. Swann , J. Carroll , H. D. M. Moore
Zygote 7 ( 4) 271 -277
8
1999
Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer.
C J Witton , S J K Hawe , T G Cooke , J M S Bartlett
Histopathology 45 ( 1) 47 -54
77
2004
Is PTEN loss associated with clinical outcome measures in human prostate cancer
P McCall , C J Witton , S Grimsley , K V Nielsen
British Journal of Cancer 99 ( 8) 1296 -1301
115
2008
Frequent amplifications and deletions of G1/S-phase transition genes, CCND1 and MYC in early breast cancers: a potential role in G1/S escape.
Linda Boye Jensen , JM Bartlett , CJ Witton , T Kirkegaard
Cancer biomarkers: section A of Disease markers 5 ( 1) 41 -49
25
2008
High ER beta expression is associated with improved survival on tamoxifen in breast cancer
CJ Witton , SM Tovey , TG Cooke , B Dunne
BREAST CANCER RESEARCH AND TREATMENT 94 S244 -S245
2005
Overexpression of HER1-3 predicts de novo tamoxifen resistance and promotes early recurrence
SM Tovey , B Dunne , CJ Witton , TG Cooke
BREAST CANCER RESEARCH AND TREATMENT 88 S33 -S33
2004
HER1-3 activates membrane ER via phosphorylation. A role for phopshorylated ER in tamoxifen resistance?
SM Tovey , B Dunne , CJ Witton , TG Cooke
BREAST CANCER RESEARCH AND TREATMENT 88 S177 -S178
2004
Characterisation of genetic changes in tamoxifen resistant breast cancer cells
DJ Scott , AT Parkes , JL Limer , CJ Witton
BREAST CANCER RESEARCH AND TREATMENT 82 S88 -S88
2003
Clinical outcome and human epithelial growth factor receptor (HER) 1-4 status in 79 invasive breast carcinomas with bromodeoxyuridine evaluated proliferation indices.
SM Tovey , CJ Witton , PD Stanton , JR Reeves
BREAST CANCER RESEARCH AND TREATMENT 82 S167 -S167
2003
Expression of cyclooxygenase 2 (COX-2) in human breast carcinomas
CJ Witton , LF Clark , TG Cooke , JMS Bartlett
BRITISH JOURNAL OF CANCER 83 38 -38
2000
Evaluation of an Automated System for Scoring Immunohistochemical Staining of HER2 in Breast Carcinoma Using Two Antibodies to HER2
CJ Witton , JJ Going , EA Mallon , TG Cooke
BREAST CANCER RESEARCH AND TREATMENT 64 ( 1) 426 -426
2000
ROLE OF N-RAS IN HORMONE RESISTANT BREAST CANCER
Liane M McGlynn , CJ Witton , JJ Going , John MS Bartlett
sPLA2 IIA expression in cancer tissues as a prerequisite for targeted liposome-based chemotherapy
BG Toft , CJ Witton , E Melander , K Jorgensen
APMIS 116 ( 3) 226 -226
2008
Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH.
Tove Kirkegaard , Caroline J Witton , Joanne Edwards , Kirsten Vang Nielsen
Histopathology 56 ( 2) 203 -211
41
2010